Home >> Media

From The Scientist:  An article about North Coast and the unique nature of this start-up model

From humble beginnings:  North Coast was founded in a 1000 sq.ft. garage converted into a lab in the fall of 2008.

The table below highlights the progression of two platforms created and designed to sample the immune repertoire efficiently and rapidly....from platform validation to clinical trials (two antibodies to date since the founding of Spaltudaq).  North Coast, by developing BLAST, has expanded the use of this approach in humans and into other mammals where massive diversity is needed.

Unique Start-up Model

a.k.a Theraclone

From platform validation to clinical trials

1

1

1

Videos
In The News
Gilead & HIVhttp://www.thepharmaletter.com/article/theraclone-out-licenses-hiv-bnabs-to-gileadhttp://www.thepharmaletter.com/article/theraclone-out-licenses-hiv-bnabs-to-gileadshapeimage_12_link_0
Videos
In The News